South Carolina Medical Marijuana Legalization Gains Momentum — And Federal Policy Shifts Could Help
South Carolina’s long-running effort to legalize medical marijuana appears to be gaining renewed momentum this year, driven by state legislative push and recent shifts in federal cannabis policy that may influence lawmakers’ calculus.
Sen. Tom Davis, a key proponent of medical cannabis reform in the Palmetto State, recently stated that legalizing medical marijuana in South Carolina is a “real possibility” as federal authorities move to reclassify marijuana and reshape the national conversation around cannabis policy.
A Doctor-Focused Medical Marijuana Proposal
For more than a decade, Davis has championed medical cannabis legislation in South Carolina. His current proposal – described by supporters as a conservative and narrowly tailored medical marijuana bill – would allow licensed physicians to recommend cannabis for patients with qualifying conditions, including chronic pain, cancer, epilepsy and other debilitating ailments.
Under the latest iteration of the bill, medical cannabis could be dispensed through a regulated system designed to emphasize patient safety. Davis’ plan prioritizes physician oversight and regulatory controls, such as strict labeling and tracking, to address traditional public safety concerns.
The Federal Context: Schedule III Rescheduling
Part of that optimism stems from developments at the federal level. Last year, President Donald Trump signed an executive order directing federal agencies to expedite the process of rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Under the CSA, Schedule I is the most restrictive classification and is reserved for drugs with “no accepted medical use” and a high potential for abuse. Moving marijuana into Schedule III – the category that includes substances like ketamine and certain anabolic steroids – would be historic because it would formally recognize marijuana’s accepted medical use under federal law, even though it would remain a controlled substance.
It’s important to note that rescheduling does not legalize marijuana federally; marijuana would still be regulated, and recreational use would remain illegal under federal law. However, Schedule III status would represent a shift in how the federal government views cannabis and could have downstream effects on research, patient access, and how state laws are perceived.
What Schedule III Could Mean
Rescheduling marijuana to Schedule III could have several practical implications that extend beyond federal policy and influence state debates:
Medical recognition: Marijuana would be acknowledged as having federal medical use, potentially encouraging more doctors to consider it as a treatment option.
Tax and business impacts: Under current federal law, cannabis businesses cannot deduct ordinary business expenses from their taxes because cannabis is a Schedule I or II substance. Schedule III classification could allow normal tax deductions, reducing financial burdens on operators.
Research expansion: Federal clinical research on cannabis might become easier as Schedule III substances face fewer regulatory barriers than Schedule I drugs, potentially leading to more robust scientific data on safety and efficacy.
Despite these potential benefits, core cannabis activities – such as distribution through state dispensaries, interstate commerce, and recreational use – would remain governed by existing federal prohibitions unless additional changes in federal law occur.
Why This Matters for South Carolina
South Carolina remains one of the few states without a comprehensive medical marijuana program, even as a majority of U.S. states have adopted medical cannabis laws. Recent national surveys show growing public support for medical marijuana access, and South Carolina is no exception – polling consistently indicates strong backing for medical cannabis among residents across party lines.
The combination of state-level legislative efforts and shifting federal cannabis policy could help overcome some of the political resistance that has stalled reform in the past. Sen. Davis has even suggested the possibility of tying the bill’s effective date to federal rescheduling, a strategic move that could make the legislation more attractive to hesitant lawmakers.
Advocates also say that acknowledging marijuana’s medical value at the federal level — even without full legalization — may reduce stigma and reassure conservative legislators concerned about federal legal conflict.
Looking Ahead
The medical cannabis bill will now continue through the South Carolina legislative process, where it may face committee hearings, floor debates, and amendments. Whether it ultimately passes both chambers and wins approval from Gov. Henry McMaster remains to be seen. In past sessions, medical cannabis measures have faced significant procedural hurdles, particularly in the House.
Still, state advocates and supporters view this moment as one of the most promising in years. Combined with a federal rescheduling push and ongoing public support, the renewed medical cannabis effort in South Carolina could signal a significant step forward in a long-standing policy debate.
Want to stay up to date on cannabis policy developments? Subscribe to our newsletter and check back with our blog for ongoing coverage of the cannabis industry at both the state and federal level.
Here are a few links to review and learn more:
Lowcountry legislator believes legalizing medical marijuana is a ‘real possibility’ | WSAV-TV
